These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1409642)

  • 1. Peptoids: a modular approach to drug discovery.
    Simon RJ; Kania RS; Zuckermann RN; Huebner VD; Jewell DA; Banville S; Ng S; Wang L; Rosenberg S; Marlowe CK
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9367-71. PubMed ID: 1409642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of N-Substituted N-Arylsulfonylglycines and Their Use in Peptoid Synthesis.
    Jobin S; Vézina-Dawod S; Herby C; Derson A; Biron E
    Org Lett; 2015 Nov; 17(22):5626-9. PubMed ID: 26550851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuning peptoid secondary structure with pentafluoroaromatic functionality: a new design paradigm for the construction of discretely folded peptoid structures.
    Gorske BC; Blackwell HE
    J Am Chem Soc; 2006 Nov; 128(44):14378-87. PubMed ID: 17076512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptoid oligomers with alpha-chiral, aromatic side chains: effects of chain length on secondary structure.
    Wu CW; Sanborn TJ; Zuckermann RN; Barron AE
    J Am Chem Soc; 2001 Apr; 123(13):2958-63. PubMed ID: 11457005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of α-chiral aromatic N-1-naphthylethyl side chains.
    Stringer JR; Crapster JA; Guzei IA; Blackwell HE
    J Am Chem Soc; 2011 Oct; 133(39):15559-67. PubMed ID: 21861531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and spectroscopic studies of peptoid oligomers with alpha-chiral aliphatic side chains.
    Wu CW; Kirshenbaum K; Sanborn TJ; Patch JA; Huang K; Dill KA; Zuckermann RN; Barron AE
    J Am Chem Soc; 2003 Nov; 125(44):13525-30. PubMed ID: 14583049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral N-substituted glycines can form stable helical conformations.
    Armand P; Kirshenbaum K; Falicov A; Dunbrack RL; Dill KA; Zuckermann RN; Cohen FE
    Fold Des; 1997; 2(6):369-75. PubMed ID: 9427011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure.
    Kirshenbaum K; Barron AE; Goldsmith RA; Armand P; Bradley EK; Truong KT; Dill KA; Cohen FE; Zuckermann RN
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4303-8. PubMed ID: 9539732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptomers: a versatile approach for the preparation of diverse combinatorial peptidomimetic bead libraries.
    Ostergaard S; Holm A
    Mol Divers; 1997; 3(1):17-27. PubMed ID: 9527474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequence.
    Holder JR; Bauzo RM; Xiang Z; Scott J; Haskell-Luevano C
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4505-9. PubMed ID: 14643357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Control the Cis-Trans Isomerization of Peptoid Amide Bonds.
    Kalita D; Sahariah B; Pravo Mookerjee S; Kanta Sarma B
    Chem Asian J; 2022 Jun; 17(11):e202200149. PubMed ID: 35362652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association of water-soluble peptoids comprising (S)-N-1-(naphthylethyl)glycine residues.
    Fuller AA; Yurash BA; Schaumann EN; Seidl FJ
    Org Lett; 2013 Oct; 15(19):5118-21. PubMed ID: 24050710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains.
    Armand P; Kirshenbaum K; Goldsmith RA; Farr-Jones S; Barron AE; Truong KT; Dill KA; Mierke DF; Cohen FE; Zuckermann RN; Bradley EK
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4309-14. PubMed ID: 9539733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational preferences of peptide-peptoid hybrid oligomers.
    Butterfoss GL; Drew K; Renfrew PD; Kirshenbaum K; Bonneau R
    Biopolymers; 2014 Sep; 102(5):369-78. PubMed ID: 24919990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptoid oligomers with alpha-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices.
    Wu CW; Sanborn TJ; Huang K; Zuckermann RN; Barron AE
    J Am Chem Soc; 2001 Jul; 123(28):6778-84. PubMed ID: 11448181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and dynamical characteristics of peptoid oligomers with achiral aliphatic side chains studied by molecular dynamics simulation.
    Park SH; Szleifer I
    J Phys Chem B; 2011 Sep; 115(37):10967-75. PubMed ID: 21819112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptoid architectures: elaboration, actuation, and application.
    Yoo B; Kirshenbaum K
    Curr Opin Chem Biol; 2008 Dec; 12(6):714-21. PubMed ID: 18786652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unconstrained peptoid tetramer exhibits a predominant conformation in aqueous solution.
    Roe LT; Pelton JG; Edison JR; Butterfoss GL; Tresca BW; LaFaye BA; Whitelam S; Wemmer DE; Zuckermann RN
    Biopolymers; 2019 Jun; 110(6):e23267. PubMed ID: 30835821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptoids and peptide-peptoid hybrid biopolymers as peptidomimetics.
    Stawikowski MJ
    Methods Mol Biol; 2013; 1081():47-60. PubMed ID: 24014433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.